Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C8 | P10632 | 6/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | CSF1R | P07333 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 4/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2471645 | 0.87 | CYP2C8 (0.57) | CYP2C8CYP3A4KCNH2NR1I2MAPK14 | |
| SCHEMBL143691 | 0.85 | CYP2C8 (0.75) | CYP2C8CYP3A4KCNH2NR1I2LCK | |
| SCHEMBL141259 | 0.85 | CYP2C8 (0.72) | CYP2C8CYP3A4KCNH2NR1I2LCK | |
| SCHEMBL2471972 | 0.85 | CYP2C8 (0.58) | CYP2C8CYP3A4KCNH2NR1I2LCK | |
| SCHEMBL145125 | 0.80 | CYP2C8 (0.75) | CYP2C8CYP3A4KCNH2NR1I2LCK | |
| SCHEMBL143635 | 0.80 | CYP2C8 (0.72) | CYP2C8CYP3A4KCNH2NR1I2LCK | |
| SCHEMBL120472 | 0.78 | CYP2C8 (0.59) | CYP2C8CYP3A4KCNH2NR1I2 | |
| SCHEMBL18751636 | 0.77 | CYP2C8 (0.59) | CYP2C8CYP3A4KCNH2NR1I2LCK | |
| SCHEMBL142368 | 0.75 | CYP2C8 (0.78) | CYP2C8CYP3A4KCNH2NR1I2LCK | |
| SCHEMBL143480 | 0.74 | CYP2C8 (0.77) | CYP2C8CYP3A4KCNH2NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2545051-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | Bristol-Myers Squibb Company (US) | 2013-01-16 | — | — | EP | disclosed |
| WO-2011112769-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-09-15 | — | — | WO | disclosed |